Cargando…
Scalable downstream method for the cyclic lipopetide jagaricin
Cyclic lipopeptides are substances with a high potential to act as antimicrobial agents. Jagaricin, produced by Janthinobacterium agaricidamnosum DSM 9628 and discovered in 2012, is a new member of this class with promising antifungal properties. However, further experiments to investigate future ap...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731587/ https://www.ncbi.nlm.nih.gov/pubmed/36514532 http://dx.doi.org/10.1002/elsc.202100079 |
_version_ | 1784845937234935808 |
---|---|
author | Stein, Jakob Schlosser, Nicolas Bardl, Bettina Peschel, Gundela Meyer, Florian Kloss, Florian Rosenbaum, Miriam A. Regestein, Lars |
author_facet | Stein, Jakob Schlosser, Nicolas Bardl, Bettina Peschel, Gundela Meyer, Florian Kloss, Florian Rosenbaum, Miriam A. Regestein, Lars |
author_sort | Stein, Jakob |
collection | PubMed |
description | Cyclic lipopeptides are substances with a high potential to act as antimicrobial agents. Jagaricin, produced by Janthinobacterium agaricidamnosum DSM 9628 and discovered in 2012, is a new member of this class with promising antifungal properties. However, further experiments to investigate future applications and/or conduct chemical derivatization to change properties and toxicity are impossible due to the limited access to jagaricin. Besides a high jagaricin concentration at the end of the fermentation process, a suitable downstream process is essential to generate appropriate amounts with the desired purity. In contrast to other amphiphilic molecules, jagaricin cannot be separated by foam fractionation since it is mainly attached to the surface of the microbial biomass. This technical report presents an overall process chain consisting of 11 individual steps to generate jagaricin in gram scale with a purity of over 95%. |
format | Online Article Text |
id | pubmed-9731587 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97315872022-12-12 Scalable downstream method for the cyclic lipopetide jagaricin Stein, Jakob Schlosser, Nicolas Bardl, Bettina Peschel, Gundela Meyer, Florian Kloss, Florian Rosenbaum, Miriam A. Regestein, Lars Eng Life Sci Technical Reports Cyclic lipopeptides are substances with a high potential to act as antimicrobial agents. Jagaricin, produced by Janthinobacterium agaricidamnosum DSM 9628 and discovered in 2012, is a new member of this class with promising antifungal properties. However, further experiments to investigate future applications and/or conduct chemical derivatization to change properties and toxicity are impossible due to the limited access to jagaricin. Besides a high jagaricin concentration at the end of the fermentation process, a suitable downstream process is essential to generate appropriate amounts with the desired purity. In contrast to other amphiphilic molecules, jagaricin cannot be separated by foam fractionation since it is mainly attached to the surface of the microbial biomass. This technical report presents an overall process chain consisting of 11 individual steps to generate jagaricin in gram scale with a purity of over 95%. John Wiley and Sons Inc. 2021-10-27 /pmc/articles/PMC9731587/ /pubmed/36514532 http://dx.doi.org/10.1002/elsc.202100079 Text en © 2021 The Authors. Engineering in Life Sciences published by Wiley‐VCH GmbH. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Technical Reports Stein, Jakob Schlosser, Nicolas Bardl, Bettina Peschel, Gundela Meyer, Florian Kloss, Florian Rosenbaum, Miriam A. Regestein, Lars Scalable downstream method for the cyclic lipopetide jagaricin |
title | Scalable downstream method for the cyclic lipopetide jagaricin |
title_full | Scalable downstream method for the cyclic lipopetide jagaricin |
title_fullStr | Scalable downstream method for the cyclic lipopetide jagaricin |
title_full_unstemmed | Scalable downstream method for the cyclic lipopetide jagaricin |
title_short | Scalable downstream method for the cyclic lipopetide jagaricin |
title_sort | scalable downstream method for the cyclic lipopetide jagaricin |
topic | Technical Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731587/ https://www.ncbi.nlm.nih.gov/pubmed/36514532 http://dx.doi.org/10.1002/elsc.202100079 |
work_keys_str_mv | AT steinjakob scalabledownstreammethodforthecycliclipopetidejagaricin AT schlossernicolas scalabledownstreammethodforthecycliclipopetidejagaricin AT bardlbettina scalabledownstreammethodforthecycliclipopetidejagaricin AT peschelgundela scalabledownstreammethodforthecycliclipopetidejagaricin AT meyerflorian scalabledownstreammethodforthecycliclipopetidejagaricin AT klossflorian scalabledownstreammethodforthecycliclipopetidejagaricin AT rosenbaummiriama scalabledownstreammethodforthecycliclipopetidejagaricin AT regesteinlars scalabledownstreammethodforthecycliclipopetidejagaricin |